Trials / Withdrawn
WithdrawnNCT02024906
Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Jill Hamilton-Reeves, PhD RD LD · Academic / Other
- Sex
- All
- Age
- 25 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to help the researchers understand if using a soy supplement impacts cardiovascular disease risk factors in patients with subclinical hypothyroidism.
Detailed description
This pilot trial is a double blind, randomized, parallel arm trial. Eighty participants with subclinical hypothyroidism will be randomized to consume either soy protein isolate or milk protein isolate for 8 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | soy protein isolate (SPI) | |
| DIETARY_SUPPLEMENT | milk protein isolate (MPI) |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2013-12-31
- Last updated
- 2015-09-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02024906. Inclusion in this directory is not an endorsement.